Grey Fox Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-60
Closed -$16.8K 155
2025
Q3
$16.8K Buy
+60
New +$17.4K ﹤0.01% 354
2023
Q2
Sell
-480
Closed -$116K 117
2023
Q1
$116K Buy
480
+17
+4% +$4.17K 0.07% 127
2022
Q4
$122K Buy
+463
New +$124K 0.08% 118

Other funds holding AMGN

Grey Fox Wealth Advisors's AMGN Position: Q4 2025 in Review

Grey Fox Wealth Advisors sold out of Amgen (AMGN) in Q4 2025, closing a stake of 60 shares — an estimated $16.8K sold.

Grey Fox Wealth Advisors first reported a position in AMGN in Q4 2022 and held it in 3 quarters. The position peaked at $122K in Q4 2022. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Grey Fox Wealth Advisors reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Grey Fox Wealth Advisors sold 60 Amgen shares in Q4 2025, an estimated $16.8K.
  • Grey Fox Wealth Advisors first reported a position in Amgen in Q4 2022 and held it in 3 quarters.
  • Grey Fox Wealth Advisors's Amgen position peaked at $122K in Q4 2022.
  • 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Grey Fox Wealth Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.